Cidara Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Cidara Therapeutics Inc
TickerCDTX
CIK #0001610618
CUSIP171757107
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address6310 Nancy Ridge Drive Suite 101, San Diego, CA 92121
Source [EDGAR]
CIK Filing 2011 - 2025
[0001610618] 10-K
[0001610618] 10-Q
[0001610618] 3
[0001610618] 4
[0001610618] 8-K
[0001610618] D
[0001610618] SC 13D
[0001610618] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Paradigm Biocapital Advisors LP Cidara Therapeutics Inc [2025-07-30] 0.0
BlackRock Inc Cidara Therapeutics Inc [2025-07-17] 0.0
Commodore Capital LP Cidara Therapeutics Inc [2025-07-02] 0.0
Adage Capital Management LP Cidara Therapeutics Inc [2025-05-12] 0.0
Point72 Asset Management LP Cidara Therapeutics Inc [2025-04-16] 0.0
Vivo Opportunity Fund Holdings LP Cidara Therapeutics Inc [2024-12-09] 5.5
Venrock Healthcare Capital Partners III LP Cidara Therapeutics Inc [2024-12-04] 0.99
TCG Crossover GP II LLC Cidara Therapeutics Inc [2024-12-03] 81949.2
Canaan XII LP Cidara Therapeutics Inc [2024-07-29] 8194.0
BCLS Fund III Investments LP Cidara Therapeutics Inc [2024-07-29] 81949.99
RA Capital Management LP Cidara Therapeutics Inc [2024-07-25] 0.99
Nantahala Capital Management LLC Cidara Therapeutics Inc [2022-02-14] 7.9
Point72 Asset Management LP Cidara Therapeutics Inc [2021-10-14] 6.3
Lytton Laurence W Cidara Therapeutics Inc [2021-03-05] 5.7
Stonepine Capital Management LLC Cidara Therapeutics Inc [2020-02-21] 5.0
Opaleye Management Inc Cidara Therapeutics Inc [2020-02-21] 11.0
Mundipharma AG Cidara Therapeutics Inc [2019-09-13] 15.2
Omega Fund V LP Cidara Therapeutics Inc [2019-02-13] 5.4
Biotechnology Value Fund L P Cidara Therapeutics Inc [2018-06-04] 6.5
Opaleye Management Inc Cidara Therapeutics Inc [2018-06-04] 11.0
Broadfin Capital LLC Cidara Therapeutics Inc [2017-07-13] 5.28
ProSight Management LP Cidara Therapeutics Inc [2017-06-16] 5.2
Lytton Laurence W Cidara Therapeutics Inc [2016-11-14] 5.3
Aisling Capital II LP Cidara Therapeutics Inc [2016-05-17] 7.4
BB Biotech AG Cidara Therapeutics Inc [2016-04-04] 5.4
Frazier Healthcare VII LP Cidara Therapeutics Inc [2016-03-29] 0.56
5AM Ventures III LP Cidara Therapeutics Inc [2016-02-12] 14.3
FMR LLC Cidara Therapeutics Inc [2015-09-10] 0.0
InterWest Partners X LP Cidara Therapeutics Inc [2015-04-23] 11.0
RA Capital Management LLC Cidara Therapeutics Inc [2015-04-21] 7.2
Form 3/4/5 Filer 2011 - 2025
RA Capital Management LP
Kolchinsky Peter
RA Capital Healthcare Fund LP
Cidara Therapeutics, Inc.
Shah Rajeev M.
Mineo Chrysa
Merson James
Canale-Theakston Carin
Spencer Ryan
Schroeder Theodore R
Resnick Joshua
Burgess Daniel D
Bassler Bonnie L
Davarpanah Nicole Negar
Ward Shane
Stein Jeffrey
Tari Leslie
Karbe Frank
Sandison Taylor
Shah Preetam
Tadvalkar Laura
Franson Timothy R
Gollaher David L
Daruwala Paul
Johnson Brady
Oien Jessica
Abdollahian Neil
Levine James E.
Mundipharma AG
Rocklage Scott M
Onaitis Matthew
Biotech Target N V
BB Biotech AG
Wilson Marc
Perez Robert J
Forrest Kevin
Bartizal Ken
Thye Dirk
Kjellson Nina S
5AM Ventures III LP
5AM Co-Investors III, L.P.
Schwab Andrew J.
Diekman John D
Elms Steve
Heron Patrick J
Judice Kevin
Schiff Andrew N
Aisling Capital II LP
Aisling Capital Partners LP
Aisling Capital Partners LLC
Seachaid Pharmaceuticals, Inc.
Purcell Dennis J
Form 13F Holdings
Firm Period DFND Voting Shares
RA Capital Management LP [2025-06-30] SOLE 3,365,523 3,365,523
Bain Capital Life Sciences Investors, LLC [2025-06-30] SOLE 2,500,680 2,500,680
Point72 Asset Management LP [2025-06-30] DFND 0 1,527,930
Vivo Capital LLC [2025-06-30] SOLE 1,311,425 1,311,425
Ikarian Capital LLC [2025-06-30] SOLE 1,287,088 1,287,088
Commodore Capital LP [2025-06-30] SOLE 1,175,000 1,175,000
BlackRock, Inc. [2025-06-30] SOLE 1,081,502 1,107,668
Adage Capital Partners GP LLC [2025-06-30] SOLE 1,100,000 1,100,000
TCG Crossover Management LLC [2025-06-30] SOLE 1,005,901 1,005,901
Vanguard Group Inc [2025-06-30] SOLE 0 953,973
Morgan Stanley [2025-06-30] DFND 877,615 883,415
BVF Inc/IL [2025-06-30] DFND 0 786,392
Darwin Global Management, Ltd. [2025-06-30] SOLE 768,424 768,424
VR Adviser LLC [2025-06-30] SOLE 639,088 639,088
Janus Henderson Group PLC [2025-06-30] DFND 0 625,000
Caption Management LLC [2025-06-30] SOLE 608,900 608,900
Vestal Point Capital LP [2025-06-30] SOLE 500,000 500,000
Susquehanna International Group LLP [2025-06-30] OTR 54,840 474,840
Soleus Capital Management LP [2025-06-30] SOLE 462,811 462,811
Boothbay Fund Management LLC [2025-06-30] OTR 0 453,926
Jefferies Financial Group Inc. [2025-06-30] DFND 450,000 450,000
Geode Capital Management LLC [2025-06-30] DFND 372,010 372,010
Citadel Advisors LLC [2025-06-30] DFND 364,151 364,151
Sofinnova Investments Inc [2025-06-30] SOLE 351,031 351,031
Stempoint Capital LP [2025-06-30] SOLE 233,070 266,774
Aberdeen Group plc [2025-06-30] DFND 259,916 259,916
LMR Partners LLP [2025-06-30] SOLE 258,200 258,200
Deep Track Capital LP [2025-06-30] SOLE 250,000 250,000
Marshall Wace LLP [2025-06-30] OTR 0 242,779
State Street Corp [2025-06-30] DFND 214,737 236,937
Prev | Page 4 | Next
Terms | Privacy | Guide
tony@aum13f.com